{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:45:12Z","timestamp":1792691112192,"version":"4.5.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T00:00:00Z","timestamp":1722038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Cancer incidence in patients with endogenous Cushing's syndrome (CS) has never been established. Here, we aimed to assess the cancer risk in patients with CS as compared with individually matched controls.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>A nationwide retrospective matched cohort study of patients with endogenous CS diagnosed between 2000 and 2023 using the database of Clalit Health Services in Israel.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Patients with adrenal carcinoma or ectopic CS were excluded. Patients with CS were matched in a 1:5 ratio, with controls individually matched for age, sex, socioeconomic status, and body mass index. The primary outcome was defined as the first diagnosis of any malignancy following a CS diagnosis. Risk of malignancy was calculated using the Cox proportional hazard model, with death as a competing event.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 609 patients with CS and 3018 controls were included [mean age at diagnosis, 48.0 \u00b1 17.2\u2005years; 2371 (65.4%) women]. The median follow-up was 14.7\u2005years (IQR, 9.9\u201320.2\u2005years). Patients with CS had an increased cancer risk, with a hazard ratio (HR) of 1.78 (95% CI 1.44\u20132.20) compared with their matched controls. The risk of malignancy was elevated in patients with Cushing's disease (251 cases and 1246 controls; HR 1.65, 95% CI 1.15\u20132.36) and in patients with adrenal CS (200 cases and 991 controls; HR 2.36, 95% CI 1.70\u20133.29). The increased cancer risk in patients with CS persists after exclusion of thyroid malignancies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Endogenous CS is associated with increased malignancy risk. These findings underscore the need for further research to establish recommendations for cancer screening in this population.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ejendo\/lvae098","type":"journal-article","created":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T15:37:16Z","timestamp":1722094636000},"page":"223-231","source":"Crossref","is-referenced-by-count":21,"title":["Endogenous Cushing's syndrome and cancer risk"],"prefix":"10.1093","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3220-6321","authenticated-orcid":false,"given":"Yaron","family":"Rudman","sequence":"first","affiliation":[{"name":"Institute of Endocrinology, Beilinson Hospital, Rabin Medical Center , Petah Tikva, 4941492 , Israel"},{"name":"Faculty of Medicine, Tel Aviv University , Tel Aviv, 6927846 , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9284-6289","authenticated-orcid":false,"given":"Maria","family":"Fleseriu","sequence":"additional","affiliation":[{"name":"Pituitary Center, Departments of Medicine and Neurological Surgery, Oregon Health & Science University , Portland, OR, 97239-3011 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3344-3006","authenticated-orcid":false,"given":"Laura","family":"Dery","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Tel Aviv University , Tel Aviv, 6927846 , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0889-8025","authenticated-orcid":false,"given":"Hiba","family":"Masri-Iraqi","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Beilinson Hospital, Rabin Medical Center , Petah Tikva, 4941492 , Israel"},{"name":"Faculty of Medicine, Tel Aviv University , Tel Aviv, 6927846 , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7175-7742","authenticated-orcid":false,"given":"Liat","family":"Sasson","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Beilinson Hospital, Rabin Medical Center , Petah Tikva, 4941492 , Israel"},{"name":"Faculty of Medicine, Tel Aviv University , Tel Aviv, 6927846 , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7576-8327","authenticated-orcid":false,"given":"Tzipora","family":"Shochat","sequence":"additional","affiliation":[{"name":"Biostatistics Unit, Rabin Medical Center, Beilinson Hospital , Petah Tikva, 4941492 , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2359-5249","authenticated-orcid":false,"given":"Shiri","family":"Kushnir","sequence":"additional","affiliation":[{"name":"Research Authority, Rabin Medical Center, Beilinson Hospital , Petah Tikva, 4941492 , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9188-3894","authenticated-orcid":false,"given":"Ilan","family":"Shimon","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Beilinson Hospital, Rabin Medical Center , Petah Tikva, 4941492 , Israel"},{"name":"Faculty of Medicine, Tel Aviv University , Tel Aviv, 6927846 , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9376-344X","authenticated-orcid":false,"given":"Amit","family":"Akirov","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Beilinson Hospital, Rabin Medical Center , Petah Tikva, 4941492 , Israel"},{"name":"Faculty of Medicine, Tel Aviv University , Tel Aviv, 6927846 , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,7,27]]},"reference":[{"issue":"2","key":"2024082910344273300_lvae098-B1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/jama.2023.11305","article-title":"Cushing syndrome: a review","volume":"330","author":"Reincke","year":"2023","journal-title":"JAMA"},{"issue":"10418","key":"2024082910344273300_lvae098-B2","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/S0140-6736(23)01961-X","article-title":"Cushing's syndrome","volume":"402","author":"Gadelha","year":"2023","journal-title":"Lancet"},{"issue":"12","key":"2024082910344273300_lvae098-B3","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing's disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"2024082910344273300_lvae098-B4","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1210\/jc.2012-3582","article-title":"Multisystem morbidity and mortality in Cushing's syndrome: a cohort study","volume":"98","author":"Dekkers","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2024082910344273300_lvae098-B5","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","article-title":"Complications of Cushing's syndrome: state of the art","volume":"4","author":"Pivonello","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"2024082910344273300_lvae098-B6","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2265.1994.tb02486.x","article-title":"Morbidity and mortality in Cushing's disease: an epidemiological approach","volume":"40","author":"Etxabe","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2024082910344273300_lvae098-B7","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/j.1365-2265.2011.04124.x","article-title":"Mortality and morbidity in Cushing's syndrome in New Zealand [published correction appears in Clin Endocrinol (Oxf). 2020 Jul; 93(1):]","volume":"75","author":"Bolland","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"2024082910344273300_lvae098-B8","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1210\/clinem\/dgac265","article-title":"The effect of endogenous Cushing syndrome on all-cause and cause-specific mortality","volume":"107","author":"Limumpornpetch","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024082910344273300_lvae098-B9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12020-017-1400-8","article-title":"Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center","volume":"58","author":"Patrova","year":"2017","journal-title":"Endocrine"},{"issue":"12","key":"2024082910344273300_lvae098-B10","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1507\/endocrj.EJ14-0155","article-title":"Long-term study of subclinical Cushing's syndrome shows high prevalence of extra-adrenal malignancy in patients with functioning bilateral adrenal tumors","volume":"61","author":"Kawate","year":"2014","journal-title":"Endocr J"},{"issue":"6","key":"2024082910344273300_lvae098-B11","doi-asserted-by":"crossref","first-page":"e234","DOI":"10.1016\/S1470-2045(13)70598-9","article-title":"Addressing overdiagnosis and overtreatment in cancer: a prescription for change","volume":"15","author":"Esserman","year":"2014","journal-title":"Lancet Oncol"},{"issue":"11","key":"2024082910344273300_lvae098-B12","doi-asserted-by":"crossref","first-page":"e0285335","DOI":"10.1371\/journal.pone.0285335","article-title":"Risk of cancer in acromegaly patients: an updated meta-analysis and systematic review","volume":"18","author":"Xiao","year":"2023","journal-title":"PLoS One"},{"issue":"7","key":"2024082910344273300_lvae098-B13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S2213-8587(22)00100-0","article-title":"Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study","volume":"10","author":"Deutschbein","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"2024082910344273300_lvae098-B14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1530\/ERC-16-0518","article-title":"Incidence of malignant tumors in patients with a non-functioning pituitary adenoma","volume":"24","author":"Olsson","year":"2017","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"2024082910344273300_lvae098-B15","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/EO-21-0033","article-title":"Pituitary tumors and the risk of other malignancies: is the relationship coincidental or causal?","volume":"2","author":"Pekic","year":"2022","journal-title":"Endocr Oncol"},{"issue":"9","key":"2024082910344273300_lvae098-B16","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1530\/ERC-16-0553","article-title":"Acromegaly is associated with increased cancer risk: a survey in Italy","volume":"24","author":"Terzolo","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"2024082910344273300_lvae098-B17","doi-asserted-by":"crossref","first-page":"1161768","DOI":"10.3389\/fendo.2023.1161768","article-title":"Glucocorticoid regulation of cancer development and progression","volume":"14","author":"Khadka","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9612","key":"2024082910344273300_lvae098-B18","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"issue":"9","key":"2024082910344273300_lvae098-B19","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.2337\/dc20-0204","article-title":"Association of type 2 diabetes with cancer: a meta-analysis with bias analysis for unmeasured confounding in 151 cohorts comprising 32 million people","volume":"43","author":"Ling","year":"2020","journal-title":"Diabetes Care"},{"key":"2024082910344273300_lvae098-B20","doi-asserted-by":"crossref","first-page":"800995","DOI":"10.3389\/fendo.2022.800995","article-title":"The relationship between diabetes mellitus and cancers and its underlying mechanisms","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2024082910344273300_lvae098-B21","first-page":"136","article-title":"Emerging mechanisms of obesity-associated immune dysfunction","volume":"21","author":"Shaikh","year":"2023","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"2024082910344273300_lvae098-B22","doi-asserted-by":"crossref","first-page":"dgz136","DOI":"10.1210\/clinem\/dgz136","article-title":"Time to diagnosis in Cushing's syndrome: a meta-analysis based on 5367 patients","volume":"105","author":"Rubinstein","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2024082910344273300_lvae098-B23","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1158\/1940-6207.CAPR-20-0161","article-title":"Long-term glucocorticoid use and cancer risk: a population-based cohort study in South Korea","volume":"13","author":"Oh","year":"2020","journal-title":"Cancer Prev Res (Phila)"},{"issue":"3","key":"2024082910344273300_lvae098-B24","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S2213-8587(20)30019-X","article-title":"Adolescent obesity and midlife cancer risk: a population-based cohort study of 2\u00b73 million adolescents in Israel","volume":"8","author":"Furer","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"2024082910344273300_lvae098-B25","doi-asserted-by":"crossref","first-page":"R157","DOI":"10.1530\/ERC-20-0489","article-title":"Duality of glucocorticoid action in cancer: tumor-suppressor or oncogene?","volume":"28","author":"Mayayo-Peralta","year":"2021","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"2024082910344273300_lvae098-B26","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1158\/1078-0432.CCR-17-0989","article-title":"The glucocorticoid receptor is a key player for prostate cancer cell survival and a target for improved antiandrogen therapy","volume":"24","author":"Puhr","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"5","key":"2024082910344273300_lvae098-B27","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/endo.143.5.8778","article-title":"A glucocorticoid-responsive mutant androgen receptor exhibits unique ligand specificity: therapeutic implications for androgen-independent prostate cancer","volume":"143","author":"Krishnan","year":"2002","journal-title":"Endocrinology"},{"issue":"3","key":"2024082910344273300_lvae098-B28","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ygyno.2017.09.013","article-title":"Expression of glucocorticoid receptor is associated with aggressive primary endometrial cancer and increases from primary to metastatic lesions","volume":"147","author":"Tangen","year":"2017","journal-title":"Gynecol Oncol"},{"key":"2024082910344273300_lvae098-B29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.mce.2017.07.004","article-title":"Possible roles for glucocorticoid signalling in breast cancer","volume":"466","author":"McNamara","year":"2018","journal-title":"Mol Cell Endocrinol"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvae098\/58666457\/lvae098.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/191\/2\/223\/58814752\/lvae098.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/191\/2\/223\/58814752\/lvae098.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T12:29:27Z","timestamp":1724934567000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/191\/2\/223\/7721884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,27]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,8,5]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvae098","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,8]]},"published":{"date-parts":[[2024,7,27]]}}}